Accès gratuit
Numéro
Med Sci (Paris)
Volume 26, Numéro 11, Novembre 2010
Page(s) 969 - 975
Section Resistance aux antibiotiques : un enjeu international
DOI https://doi.org/10.1051/medsci/20102611969
Publié en ligne 15 novembre 2010
  1. Roumagnac P, Weill FX, Dolecek C, et al. Evolutionary history of Salmonella Typhi. Science 2006 ; 314 : 1301-4.
  2. Delmas G, Haeghebaert S, de Valk J, Weill FX. Les fièvres typhoïdes et paratyphoïdes en France de 2001 à 2003. Surveillance nationale des maladies infectieuses. URL : http://www.invs.sante.fr/publications/2005/snmi/pdf/fievres_typhoides.pdf .
  3. Crump JA, Luby SP, Mintz ED. The global burden of typhoid fever. Bull World Health Organ 2004 ; 82 : 346-53.
  4. Anderson ES. The problem and implications of chloramphenicol resistance in the typhoid bacillus. J Hyg (Lond) 1975 ; 74 : 289-99.
  5. Anderson ES, Smith HR. Chloramphenicol resistance in the typhoid bacillus. Br Med J 1972 ; 3 : 329-31.
  6. Olarte J, Galindo E. Salmonella typhi resistant to chloramphenicol, ampicillin, and other antimicrobial agents: strains isolated during an extensive typhoid fever epidemic in Mexico. Antimicrob Agents Chemother 1973 ; 4 : 597-601.
  7. Datta N, Olarte J. R factors in strains of Salmonella typhi and Shigella dysenteriae 1 isolated during epidemics in Mexico: classification by compatibility. Antimicrob Agents Chemother 1974 ; 5 : 310-7.
  8. Meyruey MH, Goudineau JA, Berger P, et al. Actualité de la fièvre typhoïde au Sud Vietnam. Rev Epidemiol Med Soc Santé publique 1975 ; 23 : 345-58.
  9. Chabbert YA, Gerbaud GR. Surveillance épidémiologique des plasmides responsables de la résistance au chloramphénicol de Salmonella typhi. Ann Microbiol (Paris) 1974 ; 125A : 153-66.
  10. Goldstein FW, Chumpitaz JC, Guevara JM, et al. Plasmid-mediated resistance to multiple antibiotics in Salmonella typhi. J Infect Dis 1986 ; 153 : 261-6.
  11. Wain J, Kidgell C. The emergence of multidrug resistance to antimicrobial agents for the treatment of typhoid fever. Trans R Soc Trop Med Hyg 2004 ; 98 : 423-30.
  12. Le TA, Lejay-Collin M, Grimont PA, et al. Endemic, epidemic clone of Salmonella enterica serovar typhi harboring a single multidrug-resistant plasmid in Vietnam between 1995 and 2002. J Clin Microbiol 2004 ; 42 : 3094-9.
  13. Threlfall EJ, Ward LR. Decreased susceptibility to ciprofloxacin in Salmonella enterica serotype Typhi, United Kingdom. Emerg Infect Dis 2001 ; 7 : 448-50.
  14. Le TA, Fabre L, Roumagnac P, et al. Clonal expansion and microevolution of quinolone resistant Salmonella enterica serotype Typhi in Vietnam from 1996 to 2004. J Clin Microbiol 2007 ; 45 : 3485-92.
  15. Wain J, Hoa NT, Chinh NT, et al. Quinolone-resistant Salmonella typhi in Viet Nam: molecular basis of resistance and clinical response to treatment. Clin Infect Dis 1997 ; 25 : 1404-10.
  16. Crump JA, Barrett TJ, Nelson JT, Angulo FJ. Reevaluating fluoroquinolone breakpoints for Salmonella enterica serotype Typhi and for non-Typhi salmonellae. Clin Infect Dis 2003 ; 37 : 75-81.
  17. Aarestrup FM, Wiuff C, Mølbak K, Threlfall EJ. Is it time to change fluoroquinolone breakpoints for Salmonella spp.? Antimicrob Agents Chemother 2003 ; 47 : 827-9.
  18. Crump JA, Kretsinger K, Gay K, et al. Clinical response and outcome of infection with Salmonella enterica serotype Typhi with decreased susceptibility to fluoroquinolones: a United States foodnet multicenter retrospective cohort study. Antimicrob Agents Chemother 2008 ; 52 : 1278-84.
  19. Booker BM, Smith PF, Forrest A, et al. Application of an in vitro infection model and simulation for reevaluation of fluoroquinolone breakpoints for Salmonella enterica serotype typhi. Antimicrob Agents Chemother 2005 ; 49 : 1775-81.
  20. Smith MD, Duong NM, Hoa NT, et al. Comparison of ofloxacin and ceftriaxone for short-course treatment of enteric fever. Antimicrob Agents Chemother 1994 ; 38 : 1716-20.
  21. Tran TH, Bethell DB, Nguyen TT, et al. Short course of ofloxacin for treatment of multidrug- resistant typhoid. C!in Infect Dis 1995 ; 20 : 917-23.
  22. Nguyen TC, Solomon T, Mai XT, et al. Short courses of ofloxacin for the treatment of enteric fever. Trans R Soc Trop Med Hyg 1997 ; 91 : 347-9.
  23. Weill FX, Tran HH, Roumagnac P, et al. Clonal reconquest of antibiotic-susceptible Salmonella enterica serotype Typhi in Son La Province, Vietnam. Am J Trop Med Hyg 2007 ; 76 : 1174-81.
  24. Cooke FJ, Day M, Wain J, et al. Cases of typhoid fever imported into England, Scotland and Wales (2000-2003). Trans R Soc Trop Med Hyg 2007 ; 101 : 398-404.
  25. Lynch MF, Blanton EM, Bulens S, et al. Typhoid fever in the United States, 1999-2006. JAMA 2009 ; 302 : 859-65.
  26. Chau TT, Campbell JI, Galindo CM, et al. Antimicrobial drug resistance of Salmonella enterica serovar Typhi in asia and molecular mechanism of reduced susceptibility to the fluoroquinolones. Antimicrob Agents Chemother 2007 ; 51 : 4315-23.
  27. Gaborieau V, Weill FX, Marchou B. Salmonella enterica serovar Typhi de sensibilité diminuée à la ciprofloxacine. Med Mal Infect 2010 (sous presse).
  28. Song Y, Roumagnac P, Weill FX, et al. A multiplex single nucleotide polymorphism typing assay for detecting mutations that result in decreased fluoroquinolone susceptibility in Salmonella enterica serovars Typhi and Paratyphi A. J Antimicrob Chemother 2010 ; 65 : 1631-41.
  29. Parry CM, Ho VA, Phuong le T, et al. Randomized controlled comparison of ofloxacin, azithromycin, and an ofloxacin-azithromycin combination for treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever. Antimicrob Agents Chemother 2007 ; 51 : 819-25.
  30. Pandit A, Arjyal A, Day JN, et al. An open randomized comparison of gatifloxacin versus cefixime for the treatment of uncomplicated enteric fever. PLoS One 2007 ; 2 : e542.
  31. Dolecek C, Tran TP, Nguyen NR, et al. A multi-center randomised controlled trial of gatifloxacin versus azithromycin for the treatment of uncomplicated typhoid fever in children and adults in Vietnam. PLoS One 2008 ; 3 : e2188.
  32. Dimitrov T, Dashti AA, Albaksami O, et al. Ciprofloxacin-resistant Salmonella enterica serovar Typhi from Kuwait with novel mutations in gyrA and parC genes. J Clin Microbiol 2009 ; 47 : 208-11.
  33. Keddy KH, Smith AM, Sooka A, et al. Fluoroquinolone-resistant typhoid, South Africa. Emerg Infect Dis 2010 ; 16 : 879-80.
  34. Rotimi VO, Jamal W, Pal T, et al. Emergence of CTX-M-15 type extended-spectrum betalactamase-producing Salmonella spp. in Kuwait and the United Arab Emirates. J Med Microbiol 2008 ; 57 : 881-6.
  35. Al Naiemi N, Zwart B, Rijnsburger MC, et al. Extended-spectrum-beta-lactamase production in a Salmonella enterica serotype Typhi strain from the Philippines. J Clin Microbiol 2008 ; 46 : 2794-5.
  36. Pfeifer Y, Matten J, Rabsch W. Salmonella enterica serovar Typhi with CTX-M beta-lactamase, Germany. Emerg Infect Dis 2009 ; 15 : 1533-5.
  37. Capoor MR, Rawat D, Nair D, et al. In vitro activity of azithromycin, newer quinolones and cephalosporins in ciprofloxacin-resistant Salmonella causing enteric fever. J Med Microbiol 2007 ; 56 : 1490-4.
  38. Threlfall EJ, de Pinna E, Day M, et al. Alternatives to ciprofloxacin use for enteric fever, United Kingdom. Emerg Infect Dis 2008 ; 14 : 860-1.
  39. Boumghar-Bourtchai L, Mariani-Kurkdjian P, Bingen E, et al. Macrolide-resistant Shigella sonnei. Emerg Infect Dis 2008 ; 14 : 1297-9.
  40. Bhutta ZA. Current concepts in the diagnosis and treatment of typhoid fever. BMJ 2006 ; 333 : 78-82.

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.